<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35243620</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1600-0447</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>145</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Acta psychiatrica Scandinavica</Title>
          <ISOAbbreviation>Acta Psychiatr Scand</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder.</ArticleTitle>
        <Pagination>
          <StartPage>615</StartPage>
          <EndPage>627</EndPage>
          <MedlinePgn>615-627</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/acps.13420</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Childhood trauma affects the course of mood disorders. Researchers are now considering childhood trauma as an influential factor in the treatment of mood disorders. However, the role of childhood trauma in the treatment of bipolar disorder remains understudied.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The effect of childhood trauma on treatment outcomes was evaluated among participants randomised to treatment with lithium or quetiapine in the Clinical and Health Outcomes Initiatives in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE) study by clinician assessment. Mixed effects linear regression models were used to analyse rates of improvement in symptom severity (assessed with the Bipolar Inventory of Symptoms Scale and the Clinical Global Impression Scale for Bipolar Disorder) and functional impairment (assessed with the Longitudinal Interval Follow-up Evaluation-Range of Impaired Functioning Tool).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A history of any childhood trauma was reported by 52.7% of the sample (N = 476). Although participants with a history of any childhood trauma presented with greater symptom severity and functional impairment at most study visits, participants with and without a history of any childhood trauma showed similar rates of improvement in symptom severity and functional impairment over the 24 weeks of treatment.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This is the first study to explore the association between childhood trauma and treatment outcomes during treatment with lithium or quetiapine in the context of a randomised trial. In Bipolar CHOICE, a history of childhood trauma did not inhibit improvement in symptom severity or functional impairment. Nevertheless, these findings need replication across different settings.</AbstractText>
          <CopyrightInformation>© 2022 The Authors. Acta Psychiatrica Scandinavica published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wrobel</LastName>
            <ForeName>Anna L</ForeName>
            <Initials>AL</Initials>
            <Identifier Source="ORCID">0000-0002-1864-0394</Identifier>
            <AffiliationInfo>
              <Affiliation>IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Orygen, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Köhler-Forsberg</LastName>
            <ForeName>Ole</ForeName>
            <Initials>O</Initials>
            <Identifier Source="ORCID">0000-0001-5121-1287</Identifier>
            <AffiliationInfo>
              <Affiliation>Psychosis Research Unit, Aarhus University Hospital Psychiatry, Aarhus, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sylvia</LastName>
            <ForeName>Louisa G</ForeName>
            <Initials>LG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Russell</LastName>
            <ForeName>Samantha E</ForeName>
            <Initials>SE</Initials>
            <AffiliationInfo>
              <Affiliation>IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dean</LastName>
            <ForeName>Olivia M</ForeName>
            <Initials>OM</Initials>
            <AffiliationInfo>
              <Affiliation>IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cotton</LastName>
            <ForeName>Sue M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Orygen, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thase</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Calabrese</LastName>
            <ForeName>Joseph R</ForeName>
            <Initials>JR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deckersbach</LastName>
            <ForeName>Thilo</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Diploma Hochschule, University of Applied Sciences, Bad Sooden-Allendorf, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tohen</LastName>
            <ForeName>Mauricio</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of New Mexico Health Science Center, Albuquerque, New Mexico, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bowden</LastName>
            <ForeName>Charles L</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McInnis</LastName>
            <ForeName>Melvin G</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kocsis</LastName>
            <ForeName>James H</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Weill Cornell Medical College, New York, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Friedman</LastName>
            <ForeName>Edward S</ForeName>
            <Initials>ES</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ketter</LastName>
            <ForeName>Terence A</ForeName>
            <Initials>TA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shelton</LastName>
            <ForeName>Richard C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ostacher</LastName>
            <ForeName>Michael J</ForeName>
            <Initials>MJ</Initials>
            <Identifier Source="ORCID">0000-0003-0353-7535</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iosifescu</LastName>
            <ForeName>Dan V</ForeName>
            <Initials>DV</Initials>
            <AffiliationInfo>
              <Affiliation>NYU School of Medicine and Nathan Kline Institute, New York, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berk</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-5554-6946</Identifier>
            <AffiliationInfo>
              <Affiliation>IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Orygen, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Turner</LastName>
            <ForeName>Alyna</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nierenberg</LastName>
            <ForeName>Andrew A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Acta Psychiatr Scand</MedlineTA>
        <NlmUniqueID>0370364</NlmUniqueID>
        <ISSNLinking>0001-690X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>2S3PL1B6UJ</RegistryNumber>
          <NameOfSubstance UI="D000069348">Quetiapine Fumarate</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9FN79X2M3F</RegistryNumber>
          <NameOfSubstance UI="D008094">Lithium</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000076783" MajorTopicYN="Y">Adverse Childhood Experiences</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014150" MajorTopicYN="Y">Antipsychotic Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069348" MajorTopicYN="N">Quetiapine Fumarate</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">bipolar disorder</Keyword>
        <Keyword MajorTopicYN="N">childhood abuse</Keyword>
        <Keyword MajorTopicYN="N">lithium</Keyword>
        <Keyword MajorTopicYN="N">quetiapine</Keyword>
        <Keyword MajorTopicYN="N">treatment outcomes</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
          <Hour>5</Hour>
          <Minute>46</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35243620</ArticleId>
        <ArticleId IdType="doi">10.1111/acps.13420</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Nierenberg AA. Strategies for achieving full remission when first-line antidepressants are not enough. J Clin Psychiatry. 2013;74:e26. doi:10.4088/JCP.13018tx3c</Citation>
        </Reference>
        <Reference>
          <Citation>Judd LL, Schettler PJ, Akiskal HS, et al. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry. 2008;65:386-394. doi:10.1001/archpsyc.65.4.386</Citation>
        </Reference>
        <Reference>
          <Citation>Aldinger F, Schulze TG. Environmental factors, life events, and trauma in the course of bipolar disorder. Psychiatry Clin Neurosci. 2017;71:6-17. doi:10.1111/pcn.12433</Citation>
        </Reference>
        <Reference>
          <Citation>Palmier-Claus JE, Berry K, Bucci S, Mansell W, Varese F. Relationship between childhood adversity and bipolar affective disorder: systematic review and meta-analysis. Br J Psychiatry. 2016;209:454-459. doi:10.1192/bjp.bp.115.179655</Citation>
        </Reference>
        <Reference>
          <Citation>Sahle BW, Reavley NJ, Li W, et al. The association between adverse childhood experiences and common mental disorders and suicidality: an umbrella review of systematic reviews and meta-analyses. Eur Child Adolesc Psychiatry. 2021. doi:10.1007/s00787-021-01745-2</Citation>
        </Reference>
        <Reference>
          <Citation>Copeland WE, Shanahan L, Hinesley J, et al. Association of childhood trauma exposure with adult psychiatric disorders and functional outcomes. JAMA Network Open. 2018;1:e184493. doi:10.1001/jamanetworkopen.2018.4493</Citation>
        </Reference>
        <Reference>
          <Citation>Agnew-Blais J, Danese A. Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3:342-349. doi:10.1016/s2215-0366(15)00544-1</Citation>
        </Reference>
        <Reference>
          <Citation>Cotter J, Kaess M, Yung AR. Childhood trauma and functional disability in psychosis, bipolar disorder and borderline personality disorder: a review of the literature. Ir J Psychol Med. 2015;32:21-30. doi:10.1017/ipm.2014.74</Citation>
        </Reference>
        <Reference>
          <Citation>Klein DN, Arnow BA, Barkin JL, et al. Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depress Anxiety. 2009;26:701-710. doi:10.1002/da.20577</Citation>
        </Reference>
        <Reference>
          <Citation>Shamseddeen W, Asarnow JR, Clarke G, et al. Impact of physical and sexual abuse on treatment response in the Treatment of Resistant Depression in Adolescent Study (TORDIA). J Am Acad Child Adolesc Psychiatry. 2011;50:293-301. doi:10.1016/j.jaac.2010.11.019</Citation>
        </Reference>
        <Reference>
          <Citation>Douglas KM, Porter RJ. The effect of childhood trauma on pharmacological treatment response in depressed inpatients. Psychiatry Res. 2012;200:1058-1061. doi:10.1016/j.psychres.2012.06.015</Citation>
        </Reference>
        <Reference>
          <Citation>Nanni V, Uher R, Danese A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am J Psychiatry. 2012;169:141-151.</Citation>
        </Reference>
        <Reference>
          <Citation>Etain B, Lajnef M, Brichant-Petitjean C, et al. Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders. Acta Psychiatr Scand. 2017;135:319-327. doi:10.1111/acps.12684</Citation>
        </Reference>
        <Reference>
          <Citation>Cakir S, Tasdelen Durak R, Ozyildirim I, Ince E, Sar V. Childhood trauma and treatment outcome in bipolar disorder. J Trauma Dissociation. 2016;17:397-409. doi:10.1080/15299732.2015.1132489</Citation>
        </Reference>
        <Reference>
          <Citation>Cascino G, D'Agostino G, Monteleone AM, et al. Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder. Hum Psychopharmacol. 2021;36(4):e2783. doi:10.1002/hup.2783</Citation>
        </Reference>
        <Reference>
          <Citation>Benarous X, Raffin M, Bodeau N, Dhossche D, Cohen D, Consoli A. Adverse childhood experiences among inpatient youths with severe and early-onset psychiatric disorders: prevalence and clinical correlates. Child Psychiatry Hum Dev. 2017;48:248-259. doi:10.1007/s10578-016-0637-4</Citation>
        </Reference>
        <Reference>
          <Citation>Perugi G, Vannucchi G, Barbuti M, et al. Outcome and predictors of remission in bipolar-I patients experiencing manic episode and treated with oral antipsychotics and/or mood stabilizers: a prospective observational study in Italy. J Clin Psychopharmacol. 2018;33:131-139. doi:10.1097/yic.0000000000000211</Citation>
        </Reference>
        <Reference>
          <Citation>Spidel A, Greaves C, Yuille J, Lecomte T. A comparison of treatment adherence in individuals with a first episode of psychosis and inpatients with psychosis. Int J Law Psychiatry. 2015;39:90-98. doi:10.1016/j.ijlp.2015.01.026</Citation>
        </Reference>
        <Reference>
          <Citation>Lecomte T, Spidel A, Leclerc C, MacEwan GW, Greaves C, Bentall RP. Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis. Schizophr Res. 2008;102:295-302. doi:10.1016/j.schres.2008.01.024</Citation>
        </Reference>
        <Reference>
          <Citation>Rakofsky JJ, Levy ST, Dunlop BW. Conceptualizing treatment nonadherence in patients with bipolar disorder and PTSD. CNS Spectr. 2011;16:11-20. doi:10.1017/S1092852912000119</Citation>
        </Reference>
        <Reference>
          <Citation>Baeza-Velasco C, Olie E, Beziat S, Guillaume S, Courtet P. Determinants of suboptimal medication adherence in patients with a major depressive episode. Depress Anxiety. 2019;36:244-251. doi:10.1002/da.22852</Citation>
        </Reference>
        <Reference>
          <Citation>Lafrenaye-Dugas AJ, Godbout N, Hebert M. Cumulative childhood trauma and therapeutic alliance: the moderator role of attachment in adult patients consulting in sex therapy. J Sex Marital Ther. 2018;44:667-678. doi:10.1080/0092623X.2018.1447057</Citation>
        </Reference>
        <Reference>
          <Citation>Lawson DM, Davis D, Brandon S. Treating complex trauma: critical interventions with adults who experienced ongoing trauma in childhood. Psychotherapy (Chic). 2013;50:331-335. doi:10.1037/a0032677</Citation>
        </Reference>
        <Reference>
          <Citation>Strauss JL, Johnson SL. Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms. Psychiatry Res. 2006;145:215-223. doi:10.1016/j.psychres.2006.01.007</Citation>
        </Reference>
        <Reference>
          <Citation>Sylvia LG, Hay A, Ostacher MJ, et al. Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder. J Clin Psychopharmacol. 2013;33:343-350. doi:10.1097/JCP.0b013e3182900c6f</Citation>
        </Reference>
        <Reference>
          <Citation>Zeber JE, Copeland LA, Good CB, Fine MJ, Bauer MS, Kilbourne AM. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. J Affect Disord. 2008;107:53-62. doi:10.1016/j.jad.2007.07.026</Citation>
        </Reference>
        <Reference>
          <Citation>Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20:97-170. doi:10.1111/bdi.12609</Citation>
        </Reference>
        <Reference>
          <Citation>Nierenberg AA, Sylvia LG, Leon AC, et al. Clinical and health outcomes initiative in comparative effectiveness for bipolar disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder. Clin Trials. 2014;11:114-127. doi:10.1177/1740774513512184</Citation>
        </Reference>
        <Reference>
          <Citation>American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision ed. American Psychiatric Association; 2000.</Citation>
        </Reference>
        <Reference>
          <Citation>Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the clinical global impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73:159-171. doi:10.1016/s0165-1781(97)00123-6</Citation>
        </Reference>
        <Reference>
          <Citation>Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33.</Citation>
        </Reference>
        <Reference>
          <Citation>Alameda L, Golay P, Baumann PS, Ferrari C, Do KQ, Conus P. Age at the time of exposure to trauma modulates the psychopathological profile in patients with early psychosis. J Clin Psychiatry. 2016;77:e612-e618. doi:10.4088/JCP.15m09947</Citation>
        </Reference>
        <Reference>
          <Citation>Gonzalez JM, Bowden CL, Katz MM, et al. Development of the bipolar inventory of symptoms scale: concurrent validity, discriminant validity and retest reliability. Int J Methods Psychiatr Res. 2008;17:198-209. doi:10.1002/mpr.262</Citation>
        </Reference>
        <Reference>
          <Citation>Bowden CL, Singh V, Thompson P, et al. Development of the bipolar inventory of symptoms scale. Acta Psychiatr Scand. 2007;116:189-194. doi:10.1111/j.1600-0447.2006.00955.x</Citation>
        </Reference>
        <Reference>
          <Citation>Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB. The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med. 1999;29:869-878. doi:10.1017/s0033291799008570</Citation>
        </Reference>
        <Reference>
          <Citation>Leon AC, Solomon DA, Mueller TI, et al. A brief assessment of psychosocial functioning of subjects with bipolar I disorder: the LIFE-RIFT. Longitudinal Interval Follow-up Evaluation-Range Impaired Functioning Tool. J Nerv Ment Dis. 2000;188:805-812. doi:10.1097/00005053-200012000-00003</Citation>
        </Reference>
        <Reference>
          <Citation>Stata Statistical Software. Version 14. StataCorp LP; 2015. https://www.stata.com/stata14/</Citation>
        </Reference>
        <Reference>
          <Citation>Gueorguieva R, Krystal JH. Move over ANOVA: Progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry. 2004;61:310-317. doi:10.1001/archpsyc.61.3.310</Citation>
        </Reference>
        <Reference>
          <Citation>Maniglio R. The impact of child sexual abuse on the course of bipolar disorder: a systematic review. Bipolar Disord. 2013;15:341-358. doi:10.1111/bdi.12050</Citation>
        </Reference>
        <Reference>
          <Citation>Dualibe AL, Osório FL. Bipolar disorder and early emotional trauma: a critical literature review on indicators of prevalence rates and clinical outcomes. Harv Rev Psychiatry. 2017;25:198-208. doi:10.1097/hrp.0000000000000154</Citation>
        </Reference>
        <Reference>
          <Citation>Etain B, Aas M, Andreassen OA, et al. Childhood trauma is associated with severe clinical characteristics of bipolar disorders. J Clin Psychiatry. 2013;74:991-998. doi:10.4088/JCP.13m08353</Citation>
        </Reference>
        <Reference>
          <Citation>Conus P, Cotton S, Schimmelmann BG, et al. Pretreatment and outcome correlates of past sexual and physical trauma in 118 bipolar I disorder patients with a first episode of psychotic mania. Bipolar Disord. 2010;12:244-252. doi:10.1111/j.1399-5618.2010.00813.x</Citation>
        </Reference>
        <Reference>
          <Citation>Garno JL, Goldberg JF, Ramirez PM, Ritzler BA. Impact of childhood abuse on the clinical course of bipolar disorder. Br J Psychiatry. 2005;186(2):121-125. 10.1192/bjp.186.2.121</Citation>
        </Reference>
        <Reference>
          <Citation>Sala R, Goldstein BI, Wang S, Blanco C. Childhood maltreatment and the course of bipolar disorders among adults: epidemiologic evidence of dose-response effects. J Affect Disord. 2014;165:74-80. doi:10.1016/j.jad.2014.04.035</Citation>
        </Reference>
        <Reference>
          <Citation>Etain B, Mathieu F, Henry C, et al. Preferential association between childhood emotional abuse and bipolar disorder. J Trauma Stress. 2010;23:376-383. doi:10.1002/jts.20532</Citation>
        </Reference>
        <Reference>
          <Citation>Shannon C, Hanna D, Tumelty L, et al. Reliability of reports of childhood trauma in bipolar disorder: a test-retest study over 18 months. J Trauma Dissociation. 2016;17:511-519. doi:10.1080/15299732.2016.1141147</Citation>
        </Reference>
        <Reference>
          <Citation>Fisher HL, Craig TK, Fearon P, et al. Reliability and comparability of psychosis patients’ retrospective reports of childhood abuse. Schizophr Bull. 2011;37:546-553. doi:10.1093/schbul/sbp103</Citation>
        </Reference>
        <Reference>
          <Citation>Alameda L, Ferrari C, Baumann PS, Gholam-Rezaee M, Do KQ, Conus P. Childhood sexual and physical abuse: age at exposure modulates impact on functional outcome in early psychosis patients. Psychol Med. 2015;45:2727-2736. doi:10.1017/s0033291715000690</Citation>
        </Reference>
        <Reference>
          <Citation>Isobel S, Gladstone B, Goodyear M, Furness T, Foster K. A qualitative inquiry into psychiatrists’ perspectives on the relationship of psychological trauma to mental illness and treatment: implications for trauma-informed care. J Mental Health. 2021;30(6):667-673. doi:10.1080/09638237.2020.1714012</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
